Terms: = Cervical cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Clinical Outcome
54 results:
1. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
[TBL] [Abstract] [Full Text] [Related]
2. Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
Chopra S; Mulani J; Mittal P; Singh M; Shinde A; Gurram L; Scaria L; Aravindakshan D; Kohle S; Rane P; Ghadi Y; Rath S; Ghosh J; Gulia S; Gupta S; Kinhikar R; Laskar S; Agarwal JP
Brachytherapy; 2023; 22(2):125-131. PubMed ID: 36585283
[TBL] [Abstract] [Full Text] [Related]
3. Diffusion basis spectrum imaging predicts long-term clinical outcomes following surgery in cervical spondylotic myelopathy.
Zhang JK; Jayasekera D; Javeed S; Greenberg JK; Blum J; Dibble CF; Sun P; Song SK; Ray WZ
Spine J; 2023 Apr; 23(4):504-512. PubMed ID: 36509379
[TBL] [Abstract] [Full Text] [Related]
4. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: clinical outcome and prognostic factors.
Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
[TBL] [Abstract] [Full Text] [Related]
5. clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer.
Rogowski P; Rottler M; Walter F; Saicic S; Niyazi M; Well J; Nierer L; Trillsch F; Burges A; Mahner S; Belka C; Corradini S
Gynecol Oncol; 2022 Sep; 166(3):576-581. PubMed ID: 35764443
[TBL] [Abstract] [Full Text] [Related]
6. clinical outcome of photodynamic therapy for the treatment of cervical intraepithelial neoplasia grade 2.
Cai H; Che Y; Sun X; Yu X; Yu F; Hou F; Wang Y; Ma T
Photodiagnosis Photodyn Ther; 2022 Sep; 39():102906. PubMed ID: 35577063
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative high-dose-rate brachytherapy for high-risk early-stage cervical cancer: Long-term clinical outcome analysis.
Gauci PA; Kee DLC; Thamphya B; Schiappa R; Delotte J; Chand-Fouche ME; Hannoun-Levi JM
Brachytherapy; 2022; 21(3):273-282. PubMed ID: 35094933
[TBL] [Abstract] [Full Text] [Related]
8. clinical results of image-guided interstitial brachytherapy with or without external beam radiotherapy for postsurgical vaginal recurrence of cervical and endometrial cancers.
Kanemoto A; Sugita T; Ayukawa F; Takahashi K; Horiuchi A; Haino K; Kikuchi A
Jpn J Radiol; 2022 Jun; 40(6):639-644. PubMed ID: 34851502
[TBL] [Abstract] [Full Text] [Related]
9. Integrated analysis of virus and host transcriptomes in cervical cancer in Asian and Western populations.
Qiu Q; Zhou Q; Luo A; Li X; Li K; Li W; Yu M; Amanullah M; Lu B; Lu W; Liu P; Lu Y
Genomics; 2021 May; 113(3):1554-1564. PubMed ID: 33785400
[TBL] [Abstract] [Full Text] [Related]
10. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in cervical cancer Brachytherapy: Results From the EMBRACE I Study.
Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
[TBL] [Abstract] [Full Text] [Related]
11. Magnetic Resonance-Based Radiomic Analysis of Radiofrequency Lesion Predicts outcomes After Percutaneous Cordotomy: A Feasibility Study.
Vedantam A; Hassan I; Kotrotsou A; Hassan A; Zinn PO; Viswanathan A; Colen RR
Oper Neurosurg (Hagerstown); 2020 Jun; 18(6):721-727. PubMed ID: 31665446
[TBL] [Abstract] [Full Text] [Related]
12. Association Between Radiation Tolerance of Lymphocytes and clinical outcomes in cervical cancer.
Lee S; Cho O; Chun M; Chang SJ; Kong TW; Lee EJ; Lee Y
In Vivo; 2019; 33(6):2191-2198. PubMed ID: 31662555
[TBL] [Abstract] [Full Text] [Related]
13. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: clinical feasibility and outcome.
Mahantshetty U; Sturdza A; Naga Ch P; Berger D; Fortin I; Motisi L; Schmid MP; Aravindakshan D; Ghadi Y; Swamidas JV; Chopra S; Gurram L; Nesvacil N; Kirisits C; Pötter R
Radiother Oncol; 2019 Dec; 141():123-129. PubMed ID: 31495516
[TBL] [Abstract] [Full Text] [Related]
14. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
[TBL] [Abstract] [Full Text] [Related]
15. Is SBRT Boost Feasible for PET Positive Lymph Nodes for cervical cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
Snyder JE; Willett AB; Sun W; Kim Y
Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of Nedaplatin- and Cisplatin-Based Concurrent Chemoradiotherapy in Locally Advanced cervical cancer Patients: A Propensity Score Analysis.
Li P; Zhang R; Nie Z; Long M; Zhang G; Fu Z
Int J Gynecol Cancer; 2018 Jun; 28(5):1029-1037. PubMed ID: 29664843
[TBL] [Abstract] [Full Text] [Related]
17. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
[TBL] [Abstract] [Full Text] [Related]
18. clinical outcome of definitive radiation therapy for superficial esophageal cancer.
Koide Y; Kodaira T; Tachibana H; Tomita N; Makita C; Itoh M; Abe T; Muro K; Tajika M; Niwa Y; Itoh Y; Naganawa S
Jpn J Clin Oncol; 2017 May; 47(5):393-400. PubMed ID: 28334837
[TBL] [Abstract] [Full Text] [Related]
19. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence.
Speel EJ
Recent Results Cancer Res; 2017; 206():57-72. PubMed ID: 27699529
[TBL] [Abstract] [Full Text] [Related]
20. A volumetric analysis of GTV
Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
[TBL] [Abstract] [Full Text] [Related]
[Next]
